Beyond prescribing rights: designing equitable and sustainable attention-deficit/hyperactivity disorder care pathways in Aotearoa New Zealand

25/09/2026

AI Summary

Expanded prescribing may improve access to ADHD treatment, but without mandated training, standards and resourcing benefits may be unevenly realised.
Absence of competency standards and operational guidance risks poor diagnostic quality, missed comorbidity and unsafe prescribing in primary care.
Adult ADHD assessment is time intensive, creating workload and funding challenges; equity-centred service design and implementation frameworks are essential.

TL;DR (AI Generated)

This viewpoint article examines the clinical, ethical and service-level implications of this regulatory change, with particular attention to equity, diagnostic quality, cost and sustainability in primary care.

METHODS: This viewpoint draws on Aotearoa New Zealand policy documents, international clinical guidance and selected peer-reviewed literature to inform a policy and equity-focussed analysis of expanded stimulant prescribing authority.

Basic summary

N Z Med J. 2026 Sep 25;139(1642):156-161. doi: 10.26635/6965.7381.

ABSTRACT

AIM: From February 2026, vocationally trained general practitioners and nurse practitioners in Aotearoa New Zealand are authorised to initiate stimulant medication for adults with attention-deficit/hyperactivity disorder (ADHD), marking a shift from a predominantly secondary care model. This viewpoint article examines the clinical, ethical and service-level implications of this regulatory change, with particular attention to equity, diagnostic quality, cost and sustainability in primary care.

RESULTS: The policy change has the potential to improve access to ADHD treatment; however, the absence of mandated training, competency standards or operational guidance raises concerns about diagnostic quality, management of comorbidity and prescribing safety. The time-intensive nature of adult ADHD assessment presents workload and resourcing challenges for primary care, and multiple service delivery models are likely to emerge with variable equity implications.

CONCLUSION: Expanded prescribing authority may improve access, but without appropriate training, resourcing and implementation frameworks, benefits may be unevenly realised. Clear standards and equity-centred service design are essential.

PMID:42784829 | DOI:10.26635/6965.7381

Document this CPD